Task: Please answer the following question about the molecule with SMILES Cn1cc(C[C@@H](N)C(=O)O)c2ccccc21.
Description: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Phase 2 Clinical Trials
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Cn1cc(C[C@@H](N)C(=O)O)c2ccccc21
Cn1cc(C[C@@H](N)C(=O)O)c2ccccc21
(2R)-2-amino-3-(1-methylindol-3-yl)propanoic acid
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.